These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12185967)

  • 1. [Methods of evaluation of risks tied to drug exposure during pregnancy. Advantages and limits of epidemiology, interpretation of results].
    Robert-Gnansia E
    Therapie; 2002; 57(2):175-80. PubMed ID: 12185967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: a prospective cohort study.
    Lee SW; Han JY; Choi JS; Chung JH; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
    Reprod Toxicol; 2009 Apr; 27(2):196-8. PubMed ID: 19162171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Big risks in small groups: The difference between epidemiology and counselling.
    Friedman JM
    Birth Defects Res A Clin Mol Teratol; 2009 Aug; 85(8):720-4. PubMed ID: 19572407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-marketing surveillance system for drugs in pregnancy--15 years experience of ENTIS.
    Schaefer C; Hannemann D; Meister R
    Reprod Toxicol; 2005; 20(3):331-43. PubMed ID: 15978773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance study of Sinupret in comparison with data of the Mainz birth registry.
    Ismail C; Wiesel A; März RW; Queisser-Luft A
    Arch Gynecol Obstet; 2003 Feb; 267(4):196-201. PubMed ID: 12592417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services.
    Garbis H; Elefant E; Diav-Citrin O; Mastroiacovo P; Schaefer C; Vial T; Clementi M; Valti E; McElhatton P; Smorlesi C; Rodriguez EP; Robert-Gnansia E; Merlob P; Peiker G; Pexieder T; Schueler L; Ritvanen A; Mathieu-Nolf M
    Reprod Toxicol; 2005; 19(4):453-8. PubMed ID: 15749258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?].
    Bonnot O; Vollset SE; Godet PF; d'Amato T; Dalery J; Robert E
    Encephale; 2003; 29(6):553-9. PubMed ID: 15029090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodological issues in the epidemiological study of the teratogenicity of drugs.
    Källén BA
    Congenit Anom (Kyoto); 2005 Jun; 45(2):44-51. PubMed ID: 15904431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpretation of recurring weak associations obtained from epidemiologic studies of suspected human teratogens.
    Khoury MJ; James LM; Flanders WD; Erickson JD
    Teratology; 1992 Jul; 46(1):69-77. PubMed ID: 1641813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.
    Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA
    Clin Transpl; 2006; ():57-70. PubMed ID: 18368705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study.
    Maschi S; Clavenna A; Campi R; Schiavetti B; Bernat M; Bonati M
    BJOG; 2008 Jan; 115(2):283-9. PubMed ID: 17903222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes.
    Taguchi N; Rubin ET; Hosokawa A; Choi J; Ying AY; Moretti ME; Koren G; Ito S
    Reprod Toxicol; 2008 Oct; 26(2):175-7. PubMed ID: 18640262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.
    Bar-Oz B; Diav-Citrin O; Shechtman S; Tellem R; Arnon J; Francetic I; Berkovitch M; Ornoy A
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):31-4. PubMed ID: 18760873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation.
    Armenti VT; Radomski JS; Moritz MJ; Gaughan WJ; Philips LZ; McGrory CH; Coscia LA;
    Clin Transpl; 2002; ():121-30. PubMed ID: 12971441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on new developments in the study of human teratogens.
    Shepard TH; Brent RL; Friedman JM; Jones KL; Miller RK; Moore CA; Polifka JE
    Teratology; 2002 Apr; 65(4):153-61. PubMed ID: 11948561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy, delivery, and outcome for the child in maternal epilepsy.
    Veiby G; Daltveit AK; Engelsen BA; Gilhus NE
    Epilepsia; 2009 Sep; 50(9):2130-9. PubMed ID: 19490036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal occupational exposure to solvents and congenital malformations: a prospective study in the general population.
    Garlantézec R; Monfort C; Rouget F; Cordier S
    Occup Environ Med; 2009 Jul; 66(7):456-63. PubMed ID: 19541806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment.
    Tabacova S; Little R; Tsong Y; Vega A; Kimmel CA
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):633-46. PubMed ID: 14762979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.